A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

February 13, 2012

Primary Completion Date

November 30, 2015

Study Completion Date

February 17, 2023

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Trastuzumab

DRUG

Paclitaxel

DRUG

Lapatinib

Trial Locations (35)

Unknown

Helsinki University Hopsital, Helsinki

Kuopio University hospital, Kuopio

CRLC Val d'Aurelle, Montpellier

Interdisziplinäre Onkologische Zentrum München (IOZ München), Munich

St Vincent's University Hospital, Dublin

Cork University Hospital, Cork

Beaumont Hospital, Dublin

Mater Misericordiae University Hospital, Dublin

Mater Private Hospital, Dublin

St James's Hospital, Dublin

University Hospital Galway, Galway

Midwestern Regional Hospital, Limerick

Sligo General Hospital, Sligo

Waterford Regional Hospital, Waterford

Rabin Medical Center, Petah Tikva

The Chaim Sheba Medical Center, Tel Litwinsky

Oslo University Hopsital, Oslo

Hospital Santa Maria, Lisbon

Centro Oncologico de Galicia, A Coruña

Hospital Nuestra Senora de Sonsoles, Ávila

Hospital Infanta Cristina, Badajoz

Hospital Virgen de la Luz, Cuenca

Hospital General de Grannollers, Granollers

Complejo Hospitalario de Jaen, Jaén

Hospital Universitari Arnau de Vilanova de Lleida, Lleida

Complejo Hospitalario Xeral Calde / Hospital Lucus Augusti, Lugo

H. Puerta de Hierro, Madrid

Hospital General Universitario Gregorio Maranon, Madrid

Hospital de Mataro, Mataró

Hospital Infanta Cristina, Parla

Hospital Donostia, San Sebastián

Hospital Universitario de Canarias, Santa Cruz de Tenerife

Hospital General Universitario de Elche, Valencia

Hospital General Universitario de Valencia, Valencia

Hospital Clinico Universitario 'Lozano Blesa', Zaragoza

All Listed Sponsors
lead

Cancer Trials Ireland

NETWORK

NCT01526369 - A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter